Daniel Benítez‐Ribas

Author

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

Benitez-Ribas, D., Benitez-Ribas, Daniel, D Benitez-Ribas, D. Benitez-Ribas, D. Benítez-Ribas, Daniel Benitez-Ribas, Daniel Benitez‐Ribas, Daniel Beni´tez-Ribas, Daniel Benítez-Ribas, Daniel Benítez‐Ribas

146

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona Universitat de Barcelona Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Radboud University Nijmegen

About

Daniel Benítez‐Ribas is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in immunotherapy, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	733
2	Allergy	2	2	76
3	Engineering	1	1	13
4	Health Sciences	1	1	18
5	Natural Sciences	1	1	13

Daniel Benítez‐Ribas

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients Jurjen Tel, Erik H.J.G. Aarntzen, Tetsuro Baba, Cancer Research ImmunologyPathologyCd4 T Cell ResponsesDermatologyImmunotherapy	2013	342
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production Friederike Meyer‐Wentrup, Daniel Benítez‐Ribas, Paul J. Tacken, Blood	2008	253
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial Irati Zubizarreta, Georgina Flórez‐Grau, Gemma Vila, Proceedings of the National Academy of Sciences	2019	175
Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn’s Disease: A Phase I Study Aranzazu Jauregui-Amezaga, Raquel Cabezón, Anna Ramírez‐Morros, Journal of Crohn s and Colitis	2015	156
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies Valentín Ortiz‐Maldonado, Susana Rives, María Castellà, Molecular Therapy	2020	151
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration A.C.I. Boullart, Erik H.J.G. Aarntzen, Pauline Verdijk, Cancer Immunology Immunotherapy	2008	150
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial María Castellà, Miguel Caballero‐Baños, Valentín Ortiz‐Maldonado, Frontiers in Immunology	2020	132
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions María Castellà, Anna Boronat, Raquel Martín‐Ibáñez, Molecular Therapy — Methods & Clinical Development	2018	122
Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after FcγRII-mediated uptake Daniel Benítez‐Ribas, Gosse J. Adema, Gregor Winkels, The Journal of Experimental Medicine	2006	100
MERTK as negative regulator of human T cell activation Raquel Cabezo ́n, Eugenio Antonio Carrera Silva, Georgina Flo ́rez-Grau, Journal of Leukocyte Biology	2015	100

Page 1